AMAG Pharmaceuticals Inc

Type: Company
Name: AMAG Pharmaceuticals Inc
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Support Near $19.91

AMAG Pharmaceuticals (AMAG) presents a trading opportunity that offers a 11.05% return in just 184 days.A covered call on AMAG Pharmaceuticals at the $20.00 level expiring on Feb. '15 offers an assigned return rate of 11.05% or 21.92% annualized. This ... [Published MarketIntelligenceCenter.com - Aug 20 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Support Near $19.92

After closing Monday at $20.31, AMAG Pharmaceuticals (AMAG) presents an attractive opportunity to get a 5.49% return in just 95 days, which is an annualized return of 21.07% (for comparison purposes only). To enter this trade, sell one Nov. '14 $20.00 ... [Published MarketIntelligenceCenter.com - Aug 19 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Bullish Technicals With Resistance At $21.46

The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG"AMAG) that includes 9.07% ... [Published Individual.com - Aug 15 2014]
First reported Aug 13 2014 - Updated Aug 14 2014 - 1 reports

AMAG Pharmaceuticals elects Robert Blood as VP of Legal Affairs

Pharmaceutical company AMAG Pharmaceuticals (NasdaqGS:AMAG) disclosed on Tuesday the election of Robert Blood, Esq as vice president of its legal affairs and chief compliance officer. Blood, in the new role, will provide internal legal advice for the ... [Published Individual.com - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Potential AMAG Pharmaceuticals (AMAG) Trade Has 11.69% Downside Protection

AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG"AMAG) presents a trading opportunity that offers a 5.93% return in just 101 days.A covered call on AMAG Pharmaceuticals at the $20.00 level expiring on Nov. '14 offers an assigned ... [Published Individual.com - Aug 13 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 3 reports

AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer

WALTHAM, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Robert Blood, Esq. as vice president of legal affairs and chief compliance officer. Mr. Blood comes to AMAG with extensive experience ... [Published Scottrade - Aug 12 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Stock Investors Bid Up Shares of AMAG Pharmaceuticals, Up 2.3%

One of today's notable stocks on the rise is AMAG Pharmaceuticals (NASDAQ:AMAG), up 2.3% to $20.54. The Dow is up 0.3% to 16,415 and the S&P is currently up 0.3% to 1,916. ... [Published Individual.com - Aug 08 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Showing Bullish Technicals With Support At $19.29

The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG"AMAG) that includes 4.73% ... [Published Individual.com - Aug 08 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

AMAG Pharmaceuticals, Inc. to Participate in Jefferies Boston Healthcare Summit

WALTHAM, Mass., Aug. 1, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. ( Nasdaq:AMAG ) today announced that Frank Thomas, chief operating officer, and Scott Holmes, senior vice president of finance and investor relations, will host one-on-one meetings ... [Published Crawford Financial Planning - Aug 01 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 4 reports

AMAG Pharmaceuticals Trading 11.6% Higher Following Strong Earnings (AMAG)

AMAG Pharmaceuticals (NASDAQ:AMAG) traded up 11.6% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings, reports. The company traded as high as $20.24 and last traded at $20.03, with a volume of 787,863 ... [Published American Banking News - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 1 reports

Stock Investors Sell Off Shares of AMAG Pharmaceuticals, Down 3.2%

AMAG Pharmaceuticals (NASDAQ:AMAG) is a company whose shares are active, trading 3.2% lower to $17.85. The S&P is trading fractionally lower to 1,975 and the Dow is trading fractionally lower to 16,941. ... [Published Individual.com - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 2 reports

AMAG Pharmaceuticals beats by $0.02, beats on revenue

07:05 ET | About: AMAG Pharmaceuticals, Inc. (AMAG)AMAG Pharmaceuticals (NASDAQ:AMAG): Q2 EPS of -$0.07 beats by $0.02.Revenue of $24.8M (+26.2% Y/Y) beats by $1.4M. ... [Published Seeking Alpha - Jul 29 2014]

Quotes

...com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG "AMAG) that includes 9.07% downside protection. Sell one contract of the Feb. '15 $20.00 call for every 100 shares of AMAG for a net debit per share of about $18.55. If AMAG Pharmaceuticals closes at or above $20.00 at expiration, this trade will return 7.82% or 15.10% annualized. Support has been above $19.76 while resistance has been below $21.46. AMAG closed at $20.40 after trading between $20.29 and $21.14 Thursday."
...The publication, entitled "Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of a Mucoadhesive Hydrogel (MuGard) in Mitigating Oral Mucositis Symptoms in Patients Being Treated With Chemoradiation Therapy for Cancers of the Head and Neck" discusses data on Access' post-marketing clinical trial that evaluated the efficacy of MuGard in controlling symptoms caused by oral mucositis in 120...
AMAG Pharmaceuticals (http://www.marketintelligencecenter.com/symbol/AMAG "AMAG) presents a trading opportunity that offers a 5.93% return in just 101 days."
...senior vice president of legal affairs, general counsel and secretary at AMAG. "Robert's deep experience in the pharmaceutical and biotechnology industry and his knowledge and experience with the federal and state laws that govern the marketing and promotion of our products will be extremely valuable as we work to grow our existing product portfolio and build a diversified, multi-product pharmaceutical company that puts patients first."

More Content

All (74) | News (39) | Reports (0) | Blogs (21) | Audio/Video (0) | Fact Sheets (0) | Press Releases (14)
sort by: Date | Relevance
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 20 2014]
Business Digest for Aug. 19, 2014 [Published MetroWest Daily News - Aug 19 2014]
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 19 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published Individual.com - Aug 15 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 15 2014]
Access Pharmaceuticals Awarded Japan Patent For... [Published TickerTech.com - Aug 14 2014]
Frontrunning: August 14 [Published Zero Hedge - Aug 14 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published Individual.com - Aug 13 2014]
AMAG Pharmaceuticals elects Robert Blood as VP ... [Published Individual.com - Aug 13 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 13 2014]
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published GlobeNewswire: Advertising News - Aug 12 2014]
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published Scottrade - Aug 12 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 12 2014]
AMAG Pharmaceuticals Inc. (AMAG): Deerfield Man... [Published InsiderMonkey.com - Aug 11 2014]
AMAG Crosses Above Key Moving Average Level [Published Crawford Financial Planning - Aug 11 2014]
AMAG Pharmaceuticals (AMAG) Showing Resistance ... [Published MarketIntelligenceCenter.com - Aug 11 2014]
Stock Investors Bid Up Shares of AMAG Pharmaceu... [Published Individual.com - Aug 08 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published Individual.com - Aug 08 2014]
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 08 2014]
AMAG reports lower Q2 net loss, increases guida... [Published Individual.com - Aug 08 2014]
Iron matters for every body [Published Charlotte Post - Aug 07 2014]
Access Pharmaceuticals : Featured On OncLive.com [Published 4 Traders - Aug 06 2014]
Sunesis Pharmaceuticals Reports Second Quarter ... [Published CBS Detroit - Aug 05 2014]
AMAG Pharmaceuticals, Inc. to Participate in Je... [Published GlobeNewswire: Advertising News - Aug 01 2014]
AMAG Pharmaceuticals, Inc. to Participate in Je... [Published Crawford Financial Planning - Aug 01 2014]
AMAG Pharmaceuticals Q2 Loss Narrows as Ferahem... [Published Yahoo! Finance - Jul 30 2014]
Access Pharmaceuticals Featured On OncLive.com [Published FinanzNachrichten.de - Jul 30 2014]
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Jul 30 2014]
Sector Update: Health Care Stocks Hang On for S... [Published Nasdaq - Jul 29 2014]
AMAG Pharmaceuticals Trading 11.6% Higher Foll... [Published American Banking News - Jul 29 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 20 2014]
AMAG Pharmaceuticals (AMAG) presents a trading opportunity that offers a 11.05% return in just 184 days.A covered call on AMAG Pharmaceuticals at the $20.00 level expiring on Feb. '15 offers an assigned return rate of 11.05% or 21.92% annualized. This ...
AMAG Pharmaceuticals (AMAG) Showing Support Nea... [Published MarketIntelligenceCenter.com - Aug 19 2014]
After closing Monday at $20.31, AMAG Pharmaceuticals (AMAG) presents an attractive opportunity to get a 5.49% return in just 95 days, which is an annualized return of 21.07% (for comparison purposes only). To enter this trade, sell one Nov. '14 $20.00 ...
AMAG Pharmaceuticals (AMAG) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Aug 15 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on AMAG Pharmaceuticals (AMAG) that includes 9.07% downside protection. Sell one contract of the Feb. ...
Frontrunning: August 14 [Published Zero Hedge - Aug 14 2014]
Police fire tear gas, stun grenades at Missouri protesters ( Reuters ) Putin’s Pipeline Bypassing Ukraine at Risk Amid Conflict ( BBG ) Russia's Largest Oil Company Seeks $42 billion to Weather Sanctions ( WSJ ) Shells hit central Donetsk, Russian aid ...
Potential AMAG Pharmaceuticals (AMAG) Trade Has... [Published MarketIntelligenceCenter.com - Aug 13 2014]
AMAG Pharmaceuticals (AMAG) presents a trading opportunity that offers a 5.93% return in just 101 days.A covered call on AMAG Pharmaceuticals at the $20.00 level expiring on Nov. '14 offers an assigned return rate of 5.93% or 21.44% annualized. This trade ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
AMAG Pharmaceuticals Appoints Robert Blood as V... [Published GlobeNewswire: Advertising News - Aug 12 2014]
AMAG Pharmaceuticals, Inc. to Participate in Je... [Published GlobeNewswire: Advertising News - Aug 01 2014]
AMAG Pharmaceuticals Announces Second Quarter a... [Published GlobeNewswire: Acquisitions News - Jul 29 2014]
AMAG Pharmaceuticals, Inc. to Host Conference C... [Published GlobeNewswire: Advertising News - Jul 25 2014]
Clinical Studies, Review Extensions, Appointmen... [Published Financial Services - Jun 18 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.